Join the Oncology Voice Network. Join for Free
How I landed my first MSL role... what works, what doesn't, and what you need to know
Medical Science Liaison MSL role tips job search strategies MSL interview preparation networking for MSLs

How I landed my first MSL role... what works, what doesn't, and what you need to know


Share This Article


Summary

In this episode, Julie Chen shares her journey and insights into the MSL role, emphasizing the importance of confidence, preparation, and overcoming challenges in the job search. She discusses strategies for tailoring CVs, leveraging mentorship, and building essential skills for aspiring MSLs. Julie highlights the significance of networking and managing job search frustrations while offering advice on interview preparation and the necessity of attention to detail. The episode concludes with Julie's reflections and gratitude, followed by a call to action for listeners to engage with the content.

My guest today is Julie Chen, Medical Science Liaison at Janssen Cardiology. We discuss how she landed her first MSL role and what advice she has for aspiring MSLs looking to break into the role.

In this episode we discuss:

  • Julie’s background
  • Why she wanted to be an MSL
  • The story of her job search
  • Steps she took to initiate her search and what worked well
  • The challenges she faced
  • Her mentors/coaches
  • Absolute MUSTs for anyone seeking to land an MSL role
  • Overcoming frustrations
  • The advice she can offer and what else aspiring MSLs should keep in mind

Click for Source
Medical Science Liaison, MSL role tips, job search strategies, MSL interview preparation, networking for MSLs

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
Social Media Listening Evolved
Partner Avatar MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson

Social Media Listening Evolved

Podcast
Over-Negotiation-How to Botch a Job Offer
Partner Avatar MSL Talk: Tom Caravela

Over-Negotiation-How to Botch a Job Offer

Article
Value assessment of oncology drugs using a weighted criterion-based approach
OVN Avatar Doreen A. Ezeife MD, Francois Dionne PhD, Aline Fusco Fares MD, Ellen Laura Rose Cusano MD, Rouhi Fazelzad BSc, MISt, Wenzie Ng BSc, MPharm, RPh, Don Husereau BSc Pharm, MSc, Farzad Ali BPharm, MSc, Christina Sit MSc, Barry Stein B.Com BCL, LLB, Jennifer

Value assessment of oncology drugs using a weighted criterion-based approach

Article
Characterizing Exposure–Response Relationship for Therapeutic Monoclonal Antibodies in Immuno-Oncology and Beyond: Challenges, Perspectives, and Prospects
OVN Avatar Haiqing Isaac Dai, Yulia Vugmeyster, Naveen Mangal

Characterizing Exposure–Response Relationship for Therapeutic Monoclonal Antibodies in Immuno-Oncology and Beyond: Challenges, Perspectives, and Prospects

Article
Outcome measures for oncology alternative payment models: practical considerations and recommendations
OVN Avatar Jakub P. Hlávka, PhD, Pei-Jung Lin, PhD, Peter J. Neumann, ScD

Outcome measures for oncology alternative payment models: practical considerations and recommendations

Article
Leveraging existing data to contextualize phase II clinical trial findings in oncology
OVN Avatar E.M. Ray, L.A. Carey, K.E. Reeder-Hayes

Leveraging existing data to contextualize phase II clinical trial findings in oncology

Explore OVN